ʻO ka lāʻau lapaʻau 1190307-88-0 Sofosbuvir no ka mālama ʻana i ka maʻi Hepatitis C
Huahanainoa | Sofosbuvir |
Nā huaʻōlelo like | N-[[P(S),2'R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-L-alanine 1-methylethyl ester;PSI 7977 |
CAS No. | 1190307-88-0 |
Ka nana aku | Keʻokeʻo a keʻokeʻo keʻokeʻo crystallize pauda |
ʻĀpana Molekala | C22H29FN3O9P |
Kaumaha Molekala | 529.45 |
Hoʻohana | Ke kumu noiʻi |
Hoʻopili | E like me kāu noi |
Waihona | E mālama i loko o nā pahu paʻa a me ka māmā ma kahi anuanu |
Sofosbuvir Cas: 1190307-88-0 | ||
Nā mea | Kūlana | Nā hualoaʻa |
Ka nana aku | Keʻokeʻo a keʻokeʻo keʻokeʻo crystallize pauda | Hoʻokō |
ʻIkepili | ʻO ka manawa paʻa o ke kiʻekiʻe nui o ka hāpana hāpana e like me ka hopena maʻamau, e like me ka loaʻa ʻana ma ka hoʻāʻo no Assay | Hoʻokō |
Heheʻekiko | 118.0 ℃-128.0 ℃ | 121.9 ℃-123 ℃ |
Pohō ma ka maloʻo | NMT 0.5% | 0.16% |
Ke koena ma ka ʻā | NMT 0.2% | 0.16% |
Wai | NMT 0.5% | 0.10% |
Maʻemaʻe kiral | ʻO ka Rp-isomer: NMT 0.2% | 0.01% |
Mea pili | haumia A: NMT 0.2%haumia B: NMT 0.1% Ka haumia C: NMT 0.1% ʻO nā mea haumia ʻē aʻe: NMT 0.2% Huina haumia: NMT 1.0% | 0.03%ʻAʻole ʻike ʻia ʻAʻole ʻike ʻia 0.04% 0.16% |
Hoʻāʻo | 98.0%~102.0% | 98.78% |
Koena Solvent | Tetrahydrofuran: NMT 720ppmDichloromethane: NMT 600ppm | 0ppm0ppm |
Ka hopena:e like me nā kūlana o ka hale. |
ʻIkepili Hui
√ Ka ʻike piha o ka papa hoʻokele ma ka hale hana a me nā mea ʻenehana akamai; √ ʻO ka maikaʻi ka mea i manaʻo nui ʻia, ʻōnaehana QC koʻikoʻi; √ 11 makahiki i ʻike i ka lawe ʻana i nā hui kūʻai; √ Keʻena hana R&D kūʻokoʻa; √ ʻElua mau papa hana GMP lōʻihi i pūlima ʻia; √ Nā waiwai waiwai o nā hale hana palaualelo no ka papahana maʻamau; √ Kiʻekiʻe Efficiency hui hana me ke ala mau.E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou